Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000025.xml
Horm Metab Res 1992; 24(10): 455-457
DOI: 10.1055/s-2007-1003361
DOI: 10.1055/s-2007-1003361
Originals Basic
© Georg Thieme Verlag, Stuttgart · New York
Glucogenolytic and Hyperglycemic Effect of 33-49 C-Terminal Fragment of Pancreastatin in the Rat in Vivo
Further Information
Publication History
1991
1992
Publication Date:
14 March 2008 (online)
![](https://www.thieme-connect.de/media/hmr/199210/lookinside/thumbnails/10.1055-s-2007-1003361-1.jpg)
Summary
The effects of the 33-49 C-terminal fragment of pancreastatin on glycogen content, glycemia, insulinemia and glucagonemia were studied in the rat in vivo. It was found that after intramesenteric vein injection of the peptide, the glycogen content of liver decreased compared with control group injected with saline-1 <% BSA. Blood glucose levels were increased by the C-terminal fragment of pancreastatin. This study shows that the 33-49 C-terminal fragment of pancreatasin could play a role in glucose metabolism not mediated by insulin or glucagon.
Key words
Pancreastatin - Glycogen - Insulin - Glucagon - Glucose - Rat